Deutsche Bank
NGNE icon

Deutsche Bank’s Neurogene NGNE Stock Holding History

Deutsche Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
106,255
+20,684
+24% +$401K ﹤0.01% 1736
2025
Q4 		$1.76M Sell
85,571
-66,713
-44% -$1.66M ﹤0.01% 1868
2025
Q3 		$2.64M Buy
152,284
+1,165
+0.8% +$23.4K ﹤0.01% 1622
2025
Q2 		$2.26M Buy
151,119
+257
+0.2% +$4.03K ﹤0.01% 1629
2025
Q1 		$1.77M Sell
150,862
-1,509
-1% -$26.2K ﹤0.01% 1837
2024
Q4 		$3.48M Sell
152,371
-181,997
-54% -$6.77M ﹤0.01% 1510
2024
Q3 		$14M Buy
334,368
+2,084
+0.6% +$80.8K 0.01% 927
2024
Q2 		$12.1M Buy
332,284
+245,146
+281% +$8.65M 0.01% 946
2024
Q1 		$4.44M Buy
+87,138
New +$2.91M ﹤0.01% 1323
2022
Q2 		– Sell
-3,571
Closed -$134K – 4257
2022
Q1 		$134K Buy
3,571
+1,877
+111% +$110K ﹤0.01% 3466
2021
Q4 		$163K Buy
1,694
+600
+55% +$73.1K ﹤0.01% 3476
2021
Q3 		$157K Sell
1,094
-33
-3% -$5.05K ﹤0.01% 3686
2021
Q2 		$208K Buy
1,127
+3
+0.3% +$664 ﹤0.01% 3763
2021
Q1 		$276K Sell
1,124
-98
-8% -$25K ﹤0.01% 3462
2020
Q4 		$345K Buy
1,222
+340
+39% +$83.1K ﹤0.01% 3150
2020
Q3 		$212K Buy
882
+128
+17% +$31K ﹤0.01% 3184
2020
Q2 		$250K Buy
+754
New +$197K ﹤0.01% 3028
2019
Q4 		– Sell
-494
Closed -$28K – 5089
2019
Q3 		$28K Buy
+494
New +$30.1K ﹤0.01% 4203
2019
Q2 		– Sell
-60
Closed -$3K – 5440
2019
Q1 		$3K Buy
+60
New +$3.03K ﹤0.01% 5059
2018
Q4 		– Sell
-115
Closed -$7K – 5326
2018
Q3 		$7K Buy
115
+50
+77% +$2.95K ﹤0.01% 5148
2018
Q2 		$3K Buy
+65
New +$16.9K ﹤0.01% 5291
2018
Q1 		– Sell
-1,094
Closed -$257K – 5525
2017
Q4 		$257K Buy
1,094
+669
+157% +$157K ﹤0.01% 3913
2017
Q3 		$119K Sell
425
-1,146
-73% -$329K ﹤0.01% 4108
2017
Q2 		$442K Buy
1,571
+35
+2% +$10K ﹤0.01% 3520
2017
Q1 		$511K Buy
1,536
+16
+1% +$5.62K ﹤0.01% 3064
2016
Q4 		$501K Sell
1,520
-333
-18% -$89.5K ﹤0.01% 3172
2016
Q3 		$494K Sell
1,853
-65
-3% -$13.1K ﹤0.01% 3196
2016
Q2 		$252K Buy
1,918
+182
+10% +$28.9K ﹤0.01% 3646
2016
Q1 		$305K Buy
1,736
+116
+7% +$22.6K ﹤0.01% 3464
2015
Q4 		$403K Buy
1,620
+95
+6% +$25K ﹤0.01% 3368
2015
Q3 		$429K Sell
1,525
-422
-22% -$97.2K ﹤0.01% 3445
2015
Q2 		$270K Hold
1,947
– – ﹤0.01% 3734
2015
Q1 		$320K Sell
1,947
-1,507
-44% -$306K ﹤0.01% 3539
2014
Q4 		$517K Buy
3,454
+2,511
+266% +$358K ﹤0.01% 3646
2014
Q3 		$125K Sell
943
-205
-18% -$31.3K ﹤0.01% 4360
2014
Q2 		$216K Sell
1,148
-86
-7% -$16.6K ﹤0.01% 4080
2014
Q1 		$314K Buy
+1,234
New +$317K ﹤0.01% 3626

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Deutsche Bank's NGNE Position: Q1 2026 in Review

Deutsche Bank increased its Neurogene (NGNE) stake by 24% in Q1 2026, buying an estimated $401K and bringing the position to 106,255 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Deutsche Bank first reported a position in NGNE in Q1 2014 and has held it in 37 quarters since. The position peaked at $14M in Q3 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Deutsche Bank held 106,255 shares of Neurogene worth $2.14M as of Q1 2026.
  • Deutsche Bank bought 20,684 Neurogene shares in Q1 2026, an estimated $401K.
  • Neurogene made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1736 holding.
  • Deutsche Bank first reported a position in Neurogene in Q1 2014 and has held it in 37 quarters since.
  • Deutsche Bank's Neurogene position peaked at $14M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.